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ABSTRACT 
Modular hip implants are currently being used in total hip arthroplasty revision 
procedures because it is common to have little or no bone left in the proximal region of 
the femur and it is difficult to accurately size implants based off of radiographs or other 
medical imaging techniques.  The effect of modular systems using tapered fluted stems 
on proximal stress shielding in the human femur is the focus of this study.  Seven 
modular implants were press-fit into seven femurs, where there was little or no contact 
between the modular body and the test femur.  Finally, hydroxyapatite bone cement was 
added to create an interface between the modular body and femur.   
Stress shielding is perhaps one of the most critical complications that occur after total 
hip arthroplasty (THA).  Insertion of the prosthesis permanently alters the stress 
distribution in the human femur.  Stress shielding occurs in those areas in which a bone 
experiences a reduction of stress.  Essentially, the prosthesis “shields” the stress from the 
bone by transmitting the force through the implant rather than the bone, which can lead to 
a decrease in bone mineral density due to the reduction of stress or failure of the implant 
itself. 
Seven test femurs were instrumented with strain gages to measure the strain at three 
different levels.  Two loading conditions were applied to represent the forces exerted on 
the femur when a human is in a natural standing position.  The loading conditions were 
applied to the intact femur: when the prosthesis was inserted into the femur with a press-
fit; and when hydroxyapatite bone cement was injected around the implant in the 
proximal region. 
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All femurs exhibited stress shielding effects after surgically inserting the modular 
implants.  The experimental data confirmed that the greatest amount of stress shielding 
occurred primarily in the proximal and mid-stem regions.  The strains at the junction 
between the modular body and stem were relatively low.  The experimental data also 
confirmed that with the addition of BoneSource® Hydroxyapatite cement the strain in the 
proximal and mid-stem regions significantly increased, but stress shielding still occurred.  
The strains at the junction between the body and stem also decreased. 
 v 
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THA   Total Hip Arthroplasty 
με microstrain, the ratio of elongation with respect to the original 
length 
 
vi   Virtual Instrument 
MTS   Material Testing System 
Diaphysis  The shaft of main mid section of a long bone. 
Metaphysis The growing part of a long bone between the diaphysis and the 
epiphysis. 
 
Postero A combining form meaning posterior; postero-lateral, situated back 
and at the side. 
 
Antero A combining form meaning anterior; antero-lateral, situated front 
and at the side. 
 
Greater Trochanter A strong area at the proximal and lateral part of the shaft of the 
femur, overhanging the root of the neck; it gives attachment to the 
gluteus medius and minimus, piriformis, obturator internus and 
externus, and gemelli muscles.  
 
Cancellous  Denoting bone that has a lattice-like or spongy structure. 
 
Resorption  Loss of bone mass 
 
Stress Shielding A decrease in bone mineral density as the result of removal of 
normal stress from the bone by an implant after THA. 
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I. INTRODUCTION 
A. Background Information 
Total hip arthroplasty (THA) is one of the most widely performed orthopedic 
procedures in the United States, and its cost is a major contributor to health care costs in 
the United States.1 Modular fluted stems are being used to improve rotational stability of 
hip implants in revision surgeries.2-3 In addition, there are questions regarding the 
effectiveness of the fluted stems on proximal stress shielding and the potential for failure 
at the junction of the stem and the proximal body. 
A benefit of using modular implants is that surgeons have the freedom to 
independently size the head, body, and stem.  This means that each individual part, ie. 
head, body and stem, can be carefully selected to create a customized implant that best 
fits a particular patient’s joint. This gives a wide array of options to the surgeon in order 
to choose a size that best fits the needs of each individual patient.  Current non-invasive 
practices utilize x-rays and CT scans to predict the stem and body size needed for a total 
hip arthroplasty (THA).  During the operation the actual stem and body sizes needed may 
differ to ensure a tight fit between the implant and femur.  The surgeon can have a range 
of sizes for the head, body and stem available, whereas with a custom molded implant the 
predicted size is the only option. 
Stress shielding is defined as osteopenia occurring in bone as the result of removal of 
normal stress from the bone by an implant.4 There are many methods for quantifying the 
amount of stress shielding.  One of the most popular methods of measuring stress 
shielding effects is bone mineral density (BMD) measurements.  For example, Bulter et 
al.5 used femurs from cadavers and x-rays to quantify the amount of stress shielding 
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caused by the prosthesis.  There have been many studies showing proximal stress 
shielding caused by hip arthroplasty.6-7 After a THA the natural stress distribution on the 
femur is altered.  The implant will carry a portion of the load and distribute some of the 
load to the mid-shaft region of the femur.  This causes a reduction of stress in some areas 
of the remaining bone, primarily in the proximal region.  This phenomenon is called 
stress shielding.  Bone growth and remodeling are primarily dictated on a need basis, 
similar to muscle.  If bone experiences little or no stress there will be a loss of bone mass 
in that region.  This is known as bone resorption and can cause the prosthesis to loosen 
from the bone.  If bone experiences stress, bone mass will be maintained in that area to 
support the stress.  Studies have shown that a tighter fit in the proximal area reduces 
stress shielding and improves implant stability.8-9
B. Scope and Objectives 
The scope of this study is to investigate axial surface strains on an intact femur before 
and after the addition of BoneSource® Hydroxyapatite Bone Void Filler in the proximal 
region.  The degree of stress shielding in the proximal region before and after the addition 
of bone cement will be determined using a dual leg stance model.  The objectives for this 
study included the following: 
• Measure the proximal and mid-shaft femur surface strains using 3rd 
generation composite femurs and the dual leg stance model. 
• The surface strains for the intact femurs will be measured by loading the 
femur to 180 N and 360 N.  These strains will be used as a basis for 
determining the amount of stress shielding. 
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• Following total hip arthroplasty, the surface strains for each femur will be 
measured under load and the decrease in strain from the intact condition 
will determine the amount of stress shielding. 
• BoneSource® Hydroxyapatite bone cement will then be added around the 
proximal body to provide additional support in the proximal area. 
• The surface strains will be measured under load to determine if a 
significant reduction in stress shielding has occurred. 
• Two strain gages will be attached to the proximal body to measure the 
strains near the junction of the stem and body. 
• The proximal body strains will be measured during loading before and 




II. LITERATURE REVIEW 
It was reported that there were 234,000 total hip replacement surgeries conducted in 
2004 in the United States alone.10 The rate of hip replacements increased from 27.1 per 
10,000 population in 1995 to 37.3 in 2004.  It is the most common surgical hip procedure 
performed in adults and one of the most common major orthopedic procedures performed 
in individuals over 65 years of age.1 Kurtz et al.11 reported a relatively constant revision 
burden of 17.5% for total hip arthroplasty from 1991 to 2002, with revisions accounting 
for approximately 20% of all total hip arthroplasty cost expenditures.12   
Kurtz et al. also constructed a model to predict the future rate of revision total hip 
arthroplasty.  They projected 48,000 revisions in 2010, more than 67,000 in 2020, and 
nearly 97,000 in 2030 (a 137% increase from 2005).  Similarly, they projected a greater 
than twofold increase in primary total hip arthroplasties (from 240,000 to 570,000) from 
2005 to 2030. They also projected that the number of practicing orthopedic surgeons in 
the United States would increase from approximately 20,000 in 2010 to 26,000 in 2030. 
On the basis of their numbers, the mean case load for each surgeon would continue to 
increase from decade to decade. Moreover, the increasing volume of revisions will 
undoubtedly pose a challenge to resource utilization and cost containment.  The authors 
concluded that revision total hip arthroplasty is excellent for improving quality of life 
despite a high rate of complications in the patient population.11
There have been studies conducted to understand the characteristics and reaction 
human femurs have under many loading conditions such as the single leg stance, the two 
leg stance, and torsional loading after total hip arthroplasty (THA).2,9,12,16,17,35 These 
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studies are critical in understanding and determining the stress distribution following 
THA.   
Once an implant has been inserted, the stress distribution in the femur is dramatically 
changed.  Some of the load is now carried by the implant and is distributed to the part of 
the implant that has the tightest fit causing a reduction of stress in certain areas of the 
remaining bone.  This phenomenon is known as stress shielding.  When bone experiences 
a considerably reduced amount of stress there will be a loss of bone mass.  This 
occurrence, known as resorption, will further lead to the loosening of the prosthesis.13 
The majority of studies show that stress shielding is more prevalent in the proximal 
region of the femur. 
New studies are investigating the importance of proximal loading on the femur.  
Santori et al.14 reported that proximal loading preserves in time metaphyseal bone stock.  
Studies have been conducted to determine the effects of cement-stem debonding due to 
repetitive dynamic loading, eventually resulting in gross loosening.  Verdonschot and 
Ries found that the survival of a cemented THA is enhanced by a firm and lasting bond 
between the stem and cement mantle.   Verdonschot et al. also found that the stem-
cement debonding not only elevated the initial stress levels, but also had an impact on the 
failure process of the cement.8,15 FEA models have also been developed to predict long 
term failure in cemented implants.  By using the FEA models, experimental setups have 
been validated.16
Porous coatings help by providing a rough surface at the diaphyseal portion of the 
implant which scratches into the inner walls of the femur and interlock with it.17 Porous 
coatings also help promote better implant-bone adhesion.  The flutes on the stem engage 
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the diaphyseal cortical bone and help provide torsional stability but consequently increase 
stiffness slightly. 
It is also important to understand the risks and complications associated with revision 
THA in order to ensure longer implant life and effects to the patient.  Some of the risks 
include osteolysis and wear, infection, dislocation, periprosthetic femoral fracture, and 
nerve palsy, acetabular cup loosening, and implant loosening.  All of these risks and 
complications increase with revision surgeries and are important in understanding which 
direction research efforts can be directed to make the surgeries more effective and 
efficient.12
Stress shielding is also a large concern in revision THA.  Commonly, stress shielding 
has already occurred due to the primary THA, but it is important to slow the rate of stress 
shielding to help increase implant longevity.  This can be achieved to a certain extent by 
loading the proximal region of the femur.  By loading the proximal region of the femur 
the strains in the mid-shaft region of the femur are reduced and more bone stock is 
retained in the proximal region than if completely unloaded. 
Although the number of postmortem retrievals is limited, hydroxyapatite bone cement 
coated femoral stems consistently have shown satisfactory fixation, with little evidence of 
adverse reactions, such as osteolysis and third body wear, from hydroxyapatite particles. 
Several new technologies that are purported to improve implant fixation, minimize wear, 
and increase the survivorship and functionality of hip replacements recently have been 
introduced or are on the horizon. Only through the systematic analysis of large patient 
populations with these devices and through the analysis of failed and successful implants 
with adjacent periprosthetic tissues will we be able to establish the role that these 
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innovations will have in the treatment of the patient requiring a primary or revision hip 
replacement.18 Several animal studies have shown short-term histologic and 
biomechanical benefits associated with hydroxyapatite coating of cementless implants.19-
22 Studies of retrievals from humans also have been reported.23-27
Optimization of the variables, conditions, and considerations previously mentioned 
while still maintaining long life implant stability and minimizing stress shielding remains 
an unresolved issue in the design and use of implants.  One attempt to solve these 
problems has been the design of a modular component in which the stem and the 
proximal body are separate parts.  These modular components allow the metaphysis to be 
sized independently of the diaphysis.28 It was components of this type which were used in 
this study. 
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III. INSTRUMENTATION AND EQUIPMENT 
A. Test Specimens 
This study used seven 3rd generation composite bone models manufactured by 
Sawbones® (a division of Pacific Research Laboratories).29  Composite bones are 
designed to simulate the physical behaviors of human bone while also providing an 
alternative to cadavers for testing purposes, where special handling and precautions 
must be taken to carry out studies.  Composite bones are also anatomically accurate 
and consistent in comparison with real human femurs.  A mixture of glass fibers and 
epoxy resin pressure injected around a foam core allow the composite bone to model 
cortical bone more accurately.  The 3rd generation composite femur used in this study 
is shown in Figure 1. 
 
FIGURE 1.  Pacific Research Laboratories29 3rd generation left femur. 
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Each composite femur and corresponding hip implant was instrumented using the 
following Vishay Measurements Group, Inc.30 strain gages and equipment: 
• CEA-13-125UN-350 Uniaxial Strain Gages 
• CPF-75D Bondable Terminals 
• M-Line Mark V Soldering Station 
• M-Line M-Bond 200 Adhesive 
• M-Line 200 Catalyst-C 
• M-Line M-Coat A Air Drying Polyurethane Glue 
• Denatured Alcohol 
• M-Line 134-AWP Single Conductor Wire 
• 3 M-Line 326-DFV 3 Conductor Cable (100 ft. spools) 
• “44” Rosin Core Solder 
Four uniaxial strain gages were positioned at the proximal region of the femur, 8.5 cm 
below highest point of greater trochanter.  Four uniaxial gages were positioned 13 cm 
below highest point of greater trochanter and four uniaxial gages were positioned at the 
mid-shaft region of the femur, 25 cm below highest point of greater trochanter.  Each 
uniaxial strain gage was aligned with the femoral axis.  Bondable solder terminals, CFD-
75D, were mounted at the distal region, 32 cm below the highest point of the greater 
trochanter.  Figure 2 shows the highest point of the greater trochanter, solder terminals, 
















FIGURE 2.  Gage locations on composite test femur. 
A series of steps were taken to ensure proper gage installation.  First, a swab 
drenched in GC-6 isopropyl alcohol was used to degrease the gaging area.  Next, 220-grit 
silicon-carbide paper was used to remove any surface scale or oxide that may have been 
present on the outer surface of the composite femur.  After abrading the surface, the bone 
surface was wiped again with a swab drenched in isopropyl alcohol.  Next, a swab wetted 
with M-Prep Conditioner A was used to condition the surface and remove any impurities.  
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The M-Prep Conditioner A was wiped with a clean, dry swab before it had time to dry to 
ensure that a contaminating film was not left that could reduce the chances of a good 
bond.  Marks were made on the surface of the femur with a number two pencil to help 
properly align the strain gage.  A swab wetted with a liberal amount of M-Prep 
Neutralizer 5A was applied to the area where the gage was to be applied.  Tweezers were 
used to remove the gage from the transparent envelope and placed on a piece of scotch 
tape.  Using the marks previously made on the surface as a guide, the gage was properly 
aligned.  The gage was peeled back and a small amount of M-Line 200 Catalyst-C was 
brushed on the gage and allowed to dry for fifteen seconds.  A small amount of M-Bond 
200 was applied followed by three minutes of thumb pressure and three minutes of 
exposure to a heated lamp.  Finally, the scotch tape was peeled back at a sharp angle and 
removed.  Each gage was then wired to the bondable terminals using M-Line 134-AWP 
single conducting wires.  Approximately 91 cm of 326-DFC 3 conductor wire was 
soldered to the bondable terminals for each gage.  Labels were attached to the three lead 
conducting wires to clearly indicate its corresponding gage.  Next, the conducting wires 
were securely fastened to the femur using electrical tape.  Slack was created to ensure 
that the soldering terminals and gages were not accidentally torn off.  The last step 
involved brushing M-Coat Air Drying Polyurethane Coating over the uniaxial strain 
gages and single conducting wires to protect them from accidentally being ripped off and 
to keep moisture from damaging the gages.  The final result of the instrumentation 
process is shown in Figure 3. 
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FIGURE 3.  Distal end of femur featuring solder terminals. 
A digital multimeter was used to check for continuity and proper adhesion.  It was 
confirmed that each gage read 350 ± 1 Ω.  The gage location for each corresponding gage 
placed on each femur is listed in Table I.  Figure 4 shows the numbering convention and 
the lateral and medial regions on the anterior and posterior surfaces, respectively. 
TABLE I.  Strain gage surface and region locations on femur. 






















FIGURE 4.  Strain gage numbering convention and locations on anterior surface (left) 
and posterior surface (right). 
B. Data Acquisition Equipment 
The uniaxial strain gages from two femurs that were to be tested were wired in a one-
half Wheatstone bridge configuration and connected to a National Instruments31 SCXI 
1122 Strain-Conditioning Unit.  By using a half bridge configuration, all of the strain 
effects due to temperature change cancel out and only strains due to the applied load were 
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measured and recorded.  The circuit diagram used to configure the National Instruments31 
SCXI strain conditioning unit is shown in Figure 5 where V is the excitation voltage and 
ΔE is the output voltage. 
 
FIGURE 5.  One-half Wheatstone bridge wiring circuit. 
Figure 6 shows the laptop, junction box and the SCXI 1000, 1322, and 1122 







FIGURE 6.  Laptop, Junction Box and SCXI components. 
In order to supply the excitation voltage to the bridge all of the black leads from one 
of the test femurs were wired to the same black post, while all of the black leads from the 
other femur in the circuit were wired to the adjacent black lead on the junction box.  The 
red and white leads were wired together and clamped into the appropriate post, denoted 
as channels 0 through 15.  The junction box was used to connect the strain gages to the 
National Instruments31 SCXI 1122 module, as shown in Figure 6.  The corresponding 
voltage signals were read into National Instruments LabVIEW 6.1.31 LabVIEW 6.1 was 
used to collect, display, read, and write the measured strains values to a file.  A 
previously created LabVIEW virtual instrument (vi) was used specifically for this 
project.32 The front panel of the vi is shown in Figure 7.  
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FIGURE 7.  National Instruments31 LabVIEW virtual instrument front panel. 
The vi has many features and controls specifically designed to use in this study.  The 
stop button, channel names, scan rate, data averaging, and module input string are all 
located on the left side of the vi front panel.  Channel identification names were typed in 
the “Channel Names” box.  When data was written to a file these names appeared at the 
top of the data to clearly identify each corresponding gage.  The channels to be used for 
each experiment were selected at the top of the vi under the “SCXI-1122 Channels” 
heading.  Channels zero through eleven were used for the twelve strain gages mounted on 
each test femur and channels twelve and thirteen were used for the strain gages on the 
anterior and posterior faces, respectively, of the modular implant body.  A scan rate of 
100 scans per second for each data point was used for all tests.  The switch located at the 
center of the vi near the bottom under the heading “Femur” was used to associate the 
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strain values with the correct sign.  A positive sign denoted tension and a negative sign 
denoted compression.  This switch allowed for each femur to be tested without rewiring 
the black leads since all of the gages from one of the femurs were wired to the positive 
leg of the Wheatstone bridge circuit and the strain gages from the other test femur were 
wired to the negative leg of the bridge circuit.  The waveform chart in the middle of the vi 
displays the strains graphically and is updated after each cycle of the test.  The column 
under the heading “latest strain data” is the strain gage readings displayed digitally.  
Finally, the box in the lower left hand corner of the vi under the heading “error out” is 
where any errors that may occur will be reported which is helpful in diagnosing problems 
during data collection. 
The LavVIEW vi used in this study did not contain a calibration process to balance 
each Wheatstone bridge circuit.  Instead, an unloaded trial was conducted to obtain the 
offset surface strains for each strain gage.  Immediately afterwards, the test femur was 
loaded and the resulting strains were recorded.  The actual measured surface strain 
readings while being loaded were actually determined after taking the difference between 
the unloaded and loaded trials. 
C. Two Leg Stance Model Test Machine 
An 810 Material Testing System (MTS) located at the Belknap Research Building at 
the University of Louisville was used to produce a compressive load, consisting of axial 
and bending components, on each test femur.  A free body diagram of the loading 









FIGURE 8.  Free body diagram of loading conditions in the frontal plane view. 
The force of the upper body weight transmitted by the pelvis over the area of the 
femoral head is Fpelvis.  The force exerted on the medial and lateral condyles at the distal 
end of the femur is Ftibia.  The mechanical axis is defined as the line between the two 
forces acting on the femur in its anatomical position in a two-leg stance.  The femoral 
axis is defined as the line that is parallel to the shaft of the femur.  The angle between the 
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femoral axis and the transverse plane is θ.  The angle between the mechanical axis and 
the femoral axis is α.  For this study α was approximately 10°. 
The MTS machine included an adjustable crosshead, which was utilized to obtain the 
proper spacing for the femur and testing fixtures.  The MTS testing machine incorporated 
model 647 Hydraulic Wedge Grips on the crosshead actuator, which held the upper and 
lower test fixtures in place.  Figure 9 shows the 810 MTS machine used for this study. 
 
FIGURE 9.  MTS machine with test femur and fixtures inserted. 
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Connected to the MTS was a MTS FlexTest SE Console which was used to control 
and monitor the machine.  Once the upper and lower fixtures were put into place the axial 
load transducer was zeroed under a no load condition.  The MTS machine operated under 
displacement control to place a small amount of pre-load on each test femur before 
operating in force control to apply the appropriate load.  Under force control a specified 
amount of force was applied and maintained. 
D. Two-Leg Stance Model and Fixtures 
The testing fixtures used in this study were created in-house.33 The fixtures were 
designed to model the two leg stance and simulate the boundary conditions on the femur 
when loaded as shown in Figure 8.  A close up view of the upper and lower test fixtures 
are shown in Figures 10 and 11, respectively.  
 
50.8 x 469.9 x 19.05 bar
50.8 x 304.8 x 12.7 bar
Load Cell
Acetabular Cup
All dimensions in mm 
FIGURE 10.  Upper test fixture. 
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FIGURE 11.  Lower test fixture. 
The bottom fixture consisted of a cup with a mold filling that was specifically made to fit 
the lateral and medial condyles.   The upper and lower test fixtures held the test femur 
securely in place and created the proper boundary conditions on the femur.   
A load cell manufactured by Lebow Association Inc. (Model #3167, Serial number 
520, Capacity 200 lbs.) was mounted between the acetabular cup and fixture on the upper 
test fixture which would monitor the force exerted on the femur while the MTS was 
operating under force control.  The load cell was attached to a Measurements Group 2120 







FIGURE 12.  MTS FlexTest SE, strain conditioner, and Station Manager. 
The MTS machine was controlled by the Station Manager.  The front panel of the 
Station Manager is shown in Figure 13.  The Station Controls in the middle of the front 
panel activated the hydraulic wedge grips.  The Manual Controls in the upper right of the 
front panel switched between displacement control and force control.  The slide meter 
was used to manually position the test fixtures.  The digital displays in the bottom right of 
the front panel showed the force on the load cell within the hydraulic test fixtures 
(denoted as “Ch Force”) and the force on the 200 lb load cell between the upper test 
fixture and the Acetabular cup (denoted as “Ch Lebow”). 
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FIGURE 13.  Front panel of MTS Station Manager controller. 
E. Prosthesis 
All seven identical prostheses used in this study were modular.  The stems, proximal 
bodies, and heads were all independent components.  The modular implants are primarily 
used in revision total hip replacements and are designed so that the surgeon can select the 
appropriate size that fits each particular patient. 
All of the stems used in the study were tapered Modular Hip System Distal Fluted 
Stems manufactured by Stryker Howmedica Osteonics.34 The length of each stem was 
225 mm and the diameter of each stem was 15 mm.  All proximal bodies used in this 
study were manufactured by Stryker Howmedica Osteonics.34 The Modular Hip System 
+10 mm Proximal Body w/Bolt was used with the tapered stem.  The “w/Bolt” indicates 
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that a bolt was used to secure the body to the stem.  The seven tapered fluted stems with 
proximal bodies that were used in this study are shown in Figure 14. 
 
FIGURE 14.  Modular hip proximal bodies and stems. 
Figure 15 shows the head that was used on the proximal bodies.  The head was 
manufactured by Stryker Howmedica Osteonics.34 The head that was used on the 
proximal bodies was the 5º 38’ 37” SPD1·12.446 BC28MMNK +10. 
 
FIGURE 15.  Head used on proximal body. 
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All reamers and broaches used on the femurs were manufactured by Stryker 
Howmedica Osteonics.34 The restoration modular conical distal reamers used by the 
orthopedic surgeon that inserted the modular tapered stems are shown in Figure 16. 
 
FIGURE 16.  Stryker Howmedica Osteonics conical distal reamer set. 
Proximal cone reamers, shown in Figure 17, were used to remove the material in the 
proximal region. 
 
FIGURE 17.  Stryker Howmedica Osteonics proximal cone reamer set. 
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 Additional tools used in the implantation process included a mallet, slide hammer, 
vice, and power drill.  Figure 18 shows the Stryker Power Saw that was used to remove 
femur head. 
  






A. Experimental Phases of Study 
There were three sequential phases involved with this particular study that consisted 
of the following: 
• Phase I - Testing of intact femurs to examine initial strain distribution 
• Phase II - Insert modular implant using press fit and examine change in strain 
distribution 
• Phase III - Insert BoneSource® Hydroxyapatite bone cement around modular 
implant and examine change in strain distribution 
Phase I involved examining the strain throughout the femurs without any kind of 
modifications to the structure of the femur (i.e. no implant inserted).  Phase II was 
performed after Phase I was completed.  Modular implants were inserted and the exact 
same procedure was carried out as the intact testing and the resulting strains were 
examined and recorded.  Phase III followed Phase II.  Hydroxyapatite bone cement was 
placed around the implant and allowed to set.  The exact same procedure was carried out 
as the intact testing and the resulting strains were examined and recorded. 
B. Implementation of Hip Implants 
All seven of the modular implants were inserted by an orthopedic surgeon in the 
Orthopedic Bioengineering Laboratory at the University of Louisville medical campus.  
The process began by removing the femoral head from the femur using the Stryker Power 
Saw as shown in Figure 19. 
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FIGURE 19.  Removal of femoral head using Stryker power saw. 
A starter awl bit was used to drill down into the femur directed along the femoral axis 
to remove enough porous material to allow the reamers to remove the rest of the 
unwanted material.  The awl bit had marks in five millimeter increments starting in the 
middle and extending to the end portion of the shaft to monitor the drilling depth.  A 
drilling depth of 225 mm was used measuring from the top of the lateral side down the 
femoral axis.  This particular depth was chosen because this was the length of each of the 
stems.   
When the appropriate depth was achieved, Stryker Howmedica Osteonics reamers 
were used.  A small diameter reamer, 12.5 mm, was first employed.  As the reaming 
process continued, other reamers with increasing diameters in increments of 0.5 mm were 
used until a cavity of 15 mm was achieved.  During the reaming process the femurs were 
removed from a vice grip that held them secured so that the loose material and debris that 
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would accumulate inside the cavity could be removed.  The reaming process is shown in 
Figure 20. 
 
FIGURE 20.  Orthopedic surgeon performing reaming process. 
After all of the material and debris from the canal of the femur was removed, a large 
diameter reamer was used to remove material from the proximal region of the femur to 
insure that the modular body would not make contact with the femur.  The reaming 
process of removing all of the material in the proximal region is shown in Figure 21.   
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FIGURE 21.  Orthopedic surgeon performing reaming process. 
The material in the proximal region was also removed so that the Hydroxyapatite 
bone cement could be injected around the modular body in the third phase of this study.  
This step concluded the reaming process.  A close up view of the completed reaming 
process is shown in Figure 22. 
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FIGURE 22.  Femur after successful reaming procedure. 
The reamers and femurs became hot after an extended period of time of drilling.  The 
temperature of the femurs was monitored closely to insure that cracks would not develop 
on the femurs.  The temperature was monitored simply by touching the femurs and 
reamers.  The reaming process was halted for a short period of time if the reamers or 
femurs felt too hot to the touch.  This indicated that the reamers were contacting and 
removing the cortical bone.  This also had the potential of dulling the reamers.  The 
surgeon tried to avoid this by realigning the reamer to remove the softer material. 
The stem inserter and hammer was used to drive in the modular stem after the 
diameter of the cavity was 15 mm. The stem was hammered into position until the 225 
mm depth was reached.  A close up of the insertion of the modular stem using the stem 
inserter and hammer is shown in Figure 23. 
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FIGURE 23.  Orthopedic surgeon inserting modular stem. 
C. Alteration of Modular Body Coarse Surface 
Two uniaxial strain gages supplied from Vishay Measurements Group, Inc. were 
mounted on each modular implant body.  To ensure adequate bonding of the strain gage, 
the coarse surface on the modular body was removed.  The coarse surface on the modular 
implant is present in order to promote better implant-bone adhesion after THA. 
The coarse surface on the modular body was polished in a lathe at the University of 
Louisville Machine Shop.  In order for each modular body to be polished, a steel rod was 




FIGURE 24.  Steel rod used to secure modular body in lathe. 
The rod was inserted into the modular body and secured into place on the lathe.  
Aluminum oxide 220 grit sand paper was used to remove the coarse surface and polish 
the surface.  The process of removing the coarse surface of each implant body is shown 
in Figure 25. 
 
FIGURE 25.  Process used to remove coarse surface on modular body. 
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The time to polish each surface with the sand paper varied from three to five minutes.  
Each implant was inspected to see if the surface looked free of the coarse material.  If 
more of the coarse surface needed to be removed the lathe would be turned back on and 
more aluminum oxide 220 grit sand paper would be applied.   After the polishing 
procedure the modular bodies were removed and allowed to cool for ten minutes.  Figure 
26 shows the modular body before and after the polishing process. 
 
FIGURE 26.  Modular body before (left) and after (right) the polishing process. 
After the polishing procedure, uniaxial strain gages were mounted on the medial and 
lateral faces of the body.  Each strain gage was mounted at the bottom of the modular 
body at the interface where the body comes into contact with the tapered stem to monitor 
the strain at that point.  The location for the gages placed on each modular body, with 
respect to the test femur, is listed in Table II.  The location of the strain gages mounted on 





TABLE II.  Uniaxial strain gage surface locations on modular body. 
Gage # Surface Level
13 Anterior Proximal




FIGURE 27.  Gage number and location of strain gages on medial (left) and lateral (right) 
faces of modular body. 
Each gage was wired to bondable terminals using M-Line 134-AWP single 
conducting wires.  Approximately 61 cm of 326-DFC 3 conductor wire was soldered to 
the bondable terminals for each gage to provide strain relief.  A digital multimeter was 
used to check for continuity and proper adhesion.  It was confirmed that each gage read 
350 ± 1 Ω. 
D. Placement of Hydroxyapatite Bone Cement 
BoneSource® Hydroxyapatite, bone cement for orthopedic defect filling, was injected 
around all seven test femurs by an orthopedic surgeon in the Orthopedic Bioengineering 
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Laboratory at the University of Louisville medical campus.  The process began by mixing 
approximately 14 cc of tap water with 10.0 grams of hydroxyapatite.  A syringe with a 
flexible needle was used to inject the mixture of fluid around the body of each modular 
implant.  The injection process is shown in Figure 28. 
 
FIGURE 28.  Injection process using hydroxyapatite. 
With the excess water content, the mixture could easily flow into and fill the void 
between the implant and femur in the proximal region.  Approximately 10 cc was 
sufficient to completely fill the void in the proximal region of each test femur.  Careful 
attention was paid to make sure that the void was completely filled, especially in the 
antero-medial region.  A close-up view of the injection process is shown in Figure 29. 
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FIGURE 29.  Injection process in antero-medial region. 
The resulting construct after the hydroxyapatite bone cement was injected around the 
implant to fill the cavity between the implant and femur is shown in Figure 30. 
 
FIGURE 30.  End result of addition of hydroxyapatite bone cement. 
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Each test femur was placed upright in a storage container in an enclosed, dry area and 
allowed to cure over the course of five days to ensure that the extra moisture content had 
sufficient time to evaporate.  At the end of five days the moisture contained in the 
hydroxyapatite mixture evaporated.  Also, as a result, the hydroxyapatite bone cement 
was observed to have small surface cracks.   
E. Two Leg Stance Testing 
There were several steps incorporated into performing the two leg stance test.  First, 
the upper and lower test fixtures were inserted into the hydraulic wedge grips on the 
MTS.  Next, the Station Manager was used to adjust the crosshead to an appropriate 
height to allow the test femur to be loaded between the two fixtures.  The MTS system 
was operated in displacement control while monitoring the load.  Displacement control 
enabled the displacement of the actuator to be controlled.  Loads were placed on the 
femur by raising the actuator. 
Next, a no load test was implemented and the resulting strains were recorded.  Each 
test femur was then mounted between the fixtures of the MTS machine and secured using 
displacement control to apply a small amount of pre-load on the femur.  Then, the Station 
Manager was switched into force control.  A load cell mounted between the upper test 
fixture and acetabular cup was connected to a Measurements Group 2120 which 
monitored the force exerted on the test femur.  A compressive load of 180 N was 
administered.  After the strain readings were recorded the test femur was removed from 
the MTS machine and allowed to rest for ten minutes to allow the test femur to relax and 
the strains to return to the no load level as reported in a study conducted by Fries.35 This 
process was repeated except a 360 N compressive load was applied to each test femur, 
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which is half the weight of an average male.  The entire process was repeated three times 
on each test femur to determine data repeatability. 
The LabVIEW vi used in this study did not incorporate a calibration process to zero 
out the strains, thus what is referred to in this study as “zero strain condition” test was the 
zero load strain.  Then a trial was carried out in which the load was placed on the femur.  
Only after the difference was taken between the loaded and unloaded trials was the actual 
strain experienced by the femur resolved. 
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V. RESULTS 
A. Press Fit Prosthesis Strain Data 
For the intact condition (Phase I) the strains were largest in the proximal region and 
lowest in the distal region.  Figures 31 and 32 show the intact surface strains and the 
surface strains after the insertion of the modular implant for femur #4139 and the average 
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FIGURE 32.  Resulting average intact strains and press fit strains with a 360 N load of all 
femurs. 
The strains were compressive on the medial side of the femur and tensile on the 
lateral side.  Note for all results presented that a negative strain value denotes that the 
strain gage is in compression and a positive strain value denotes that the strain gage is in 
tension.  Overall, stress shielding occurred in every region except the distal-stem level 
antero-lateral and postero-medial areas.  Similar results were obtained from the other six 
test femurs as shown in the appendix.  The percent decrease in surface strain from the 
intact state to the press fit state for each test femur under 180 N and 360 N compressive 






TABLE III.  Percent decrease between intact and press fit cases with a 180 N load. 
4139 4140 4141 4142 4470 4471 4472
1 95.4 99.8 97.8 97.7 99.3 99.3 98.0
2 98.8 99.7 98.8 95.0 97.8 89.9 95.4
3 97.2 96.3 97.9 94.6 99.9 95.1 98.6
4 99.2 98.2 99.3 98.8 97.9 95.6 99.7
5 88.8 65.9 90.5 83.0 96.3 70.3 97.1
6 91.2 37.0 53.4 32.8 77.2 60.7 52.5
7 47.8 90.5 82.8 39.7 97.4 66.9 80.3
8 92.3 23.3 42.4 54.9 76.8 65.1 50.7
9 17.1 8.2 -16.5 -4.5 32.4 42.2 38.4
10 -8.3 -14.3 15.7 -6.1 -2.2 -32.9 -26.6
11 31.4 42.3 44.8 17.4 75.7 92.3 72.8










TABLE IV.  Percent decrease between intact and press fit cases with a 360 N load. 
4139 4140 4141 4142 4470 4471 4472
1 97.4 99.8 97.2 99.7 99.6 99.5 98.6
2 99.3 99.7 99.0 97.4 100.0 95.7 97.9
3 98.3 98.8 99.3 92.2 99.9 97.7 98.5
4 99.3 97.4 99.1 99.5 98.8 97.3 99.5
5 91.9 57.2 95.8 83.5 91.6 72.6 98.6
6 99.7 43.3 55.3 34.5 74.9 71.4 53.3
7 50.9 81.6 85.0 24.8 89.1 74.4 80.7
8 99.8 25.0 56.1 54.9 75.1 74.0 51.4
9 16.7 8.6 -19.0 -7.1 30.5 44.4 39.7
10 -9.0 -10.9 12.3 -6.8 -4.3 -33.8 -23.2
11 28.9 27.6 30.9 20.3 71.8 98.9 81.2










Overall, there was a significant drop in surface strain on the femurs since ten of the 
twelve strain gages experienced a reduction of strain under each load condition.  
B. Cemented Prosthesis Data 
After administering the hydroxyapatite bone cement around the modular implant, the 
strain distribution throughout the femur changed. Figures 33 and 34 show the intact 
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surface strains and the surface strains after administering the hydroxyapatite bone cement 
under a 360 N load for femur #4139 and the average surface strains of all of the test 
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FIGURE 34.  Resulting average intact strains and cemented strains with a 360 N load of 
all femurs. 
Similar results were obtained from the other six test femurs as shown in the appendix.  
The percent decrease in surface strain from the intact state and with the addition of 
hydroxyapatite state for each test femur with 180 N and 360 N load conditions is shown 









TABLE V.  Percent decrease between intact state and with the addition of hydroxyapatite 
bone cement with a 180 N load. 
4139 4140 4141 4142 4470 4471 4472
1 32.6 51.3 67.4 51.9 70.5 52.9 76.2
2 47.4 36.9 40.5 28.3 31.7 43.8 49.6
3 70.2 56.8 65.4 57.4 63.2 42.2 65.1
4 58.2 48.1 62.3 60.7 65.0 50.4 60.4
5 34.2 20.1 43.5 45.9 55.8 29.7 62.4
6 14.6 3.0 7.5 6.8 9.3 28.7 3.7
7 27.3 24.4 21.2 15.6 34.6 15.5 72.3
8 21.9 9.9 27.2 24.5 28.8 36.1 16.8
9 11.3 6.3 22.8 20.9 42.8 20.7 35.4
10 -25.0 -4.6 1.8 -15.7 -10.7 -6.7 -23.6
11 40.4 36.3 -21.8 31.5 49.2 60.6 78.8











TABLE VI.  Percent decrease between intact state and with the addition of 
hydroxyapatite bone cement with a 360 N load. 
4139 4140 4141 4142 4470 4471 4472
1 25.6 46.7 66.5 52.4 67.3 50.0 72.6
2 45.9 39.2 43.8 33.5 41.0 49.1 52.0
3 63.0 55.0 65.2 52.8 67.1 40.0 70.4
4 53.5 44.9 60.6 51.5 64.0 48.7 56.9
5 28.9 13.7 36.9 37.7 49.9 23.6 58.6
6 10.4 3.6 8.5 8.1 12.0 29.6 7.7
7 27.2 22.4 20.8 19.1 39.6 9.6 79.4
8 20.3 10.4 21.9 20.1 26.8 36.2 16.9
9 10.3 6.0 14.1 17.7 26.4 16.5 34.8
10 -20.9 -7.0 2.3 -11.7 -10.5 -10.9 -21.4
11 39.4 33.5 -20.8 22.2 67.0 53.0 86.7











C. Modular Body Strain Data 
  The resulting strains on the modular bodies were measured before and after the 
addition of the hydroxyapatite bone cement.  Overall, the surface strains recorded were 
relatively low.  Figures 35 and 36 show the measured surface strains on the medial and 
lateral faces of the modular bodies under a load of 180 N and 360 N for femur #4139 and 
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FIGURE 36.  Resulting average surface strains on body for all femurs. 
  The maximum surface strain was 98 με in compression in response to a 180 N 
compressive load on femur #4142.  The maximum surface strain was 207 με in 
compression in response to a 360 N compressive load on femur #4472.  Similar results 
were obtained from the other test femurs as shown in the appendix.  On average the 
surface strains were reduced by 20% after adding Hydroxyapatite bone cement. 
D. Linearity and Repeatability of Load Cases 
Shown in Tables VII and VIII is the percent strain difference between the 180 N 
loading cases and 360 N loading cases in the intact state and with the addition of the 




TABLE VII.  Percent strain difference between 180 N and 360 N for intact case. 
4139 4140 4141 4142 4470 4471 4472
1 50.2 50.9 47.5 52.0 49.0 52.3 50.6
2 44.6 50.4 51.4 47.3 48.7 46.5 45.1
3 50.9 50.5 48.0 55.6 49.9 50.9 48.9
4 50.2 51.3 50.4 50.7 47.2 49.5 48.8
5 49.8 58.0 44.7 51.9 52.7 51.2 49.0
6 46.5 43.3 50.7 47.9 52.8 41.9 47.3
7 50.0 59.8 44.9 82.2 54.6 47.8 47.4
8 46.9 46.5 39.0 51.5 51.7 43.7 48.4
9 54.0 49.4 36.1 33.3 53.5 45.9 45.9
10 46.8 66.9 69.5 47.6 26.8 50.6 56.8
11 57.7 78.5 62.9 49.6 51.3 45.3 42.6
12 55.7 71.5 56.1 49.5 44.5 52.3 74.1











TABLE VIII.  Percent strain difference between 180 N and 360 N for cemented case. 
4139 4140 4141 4142 4470 4471 4472
1 65.4 56.0 47.9 52.6 51.5 55.4 53.3
2 46.3 47.4 47.7 41.0 38.6 44.2 44.2
3 57.3 53.6 48.9 58.9 47.0 55.3 45.2
4 54.7 54.5 51.7 60.2 48.4 52.1 51.7
5 61.0 73.7 55.6 63.5 56.0 66.5 53.0
6 71.3 41.5 46.5 42.4 39.6 47.9 23.3
7 53.3 58.6 47.1 41.8 43.7 85.6 43.3
8 54.7 47.7 64.3 62.9 54.2 49.5 48.7
9 57.9 54.7 67.1 62.2 81.8 60.4 48.3
10 60.6 33.7 43.4 71.6 53.6 32.1 54.7
11 54.4 55.2 45.6 82.0 35.7 55.5 43.2
12 32.3 55.3 58.4 45.6 61.2 48.7 57.7










The experimental data from Tables VII and VIII show that the magnitude of the 
strains for the 180 N load cases were approximately half of the magnitude of the strains 
for the 360 N load cases the intact and press cemented states. 
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By using a load cell with a relatively small range, the resulting measured strains were 
more accurate.  The strain mean and standard deviation between the three trials for both 
the 180 N and 360 N load cases for femur #4139 are shown in Tables IX and X.  The 
seven-femur average strain mean and standard deviation between the three trials for both 
180 N and 360 N load cases are shown in Tables XI and XII. 
TABLE IX.  Mean and standard deviation between trials under 180 N for femur #4139. 
Mean St. Dev. Mean St. Dev. Mean St. Dev.
1 -107.4 1.1 -5.0 2.0 -72.4 3.5
2 98.4 25.7 1.2 1.0 51.8 8.6
3 82.1 3.4 2.3 0.6 24.5 3.0
4 -234.1 40.5 -2.0 0.7 -97.8 19.3
5 -137.2 5.8 -15.3 1.8 -90.3 19.8
6 153.5 8.4 13.6 4.2 131.1 7.9
7 63.7 6.3 33.2 3.0 46.3 3.7
8 -209.8 3.9 -16.2 3.1 -163.9 20.0
9 -91.6 7.3 -76.0 4.1 -81.3 11.2
10 124.1 8.4 134.4 6.5 155.1 39.0
11 48.8 8.1 33.5 4.3 29.1 10.4
12 -156.2 6.7 -166.5 3.8 -174.1 4.2
Medial face on 
implant head 13 - - -56.7 1.3 -43.9 13.2
Lateral face on 
implant head 14 - - 51.5 12.9 31.2 4.9

















TABLE X.  Mean and standard deviation between trials under 360 N for femur #4139. 
Mean St. Dev. Mean St. Dev. Mean St. Dev.
1 -209.5 7.3 -5.5 2.6 -155.9 1.1
2 219.4 2.8 1.6 1.3 118.6 6.4
3 159.6 3.7 2.7 1.6 59.0 3.0
4 -465.7 26.9 -3.0 1.1 -216.4 7.0
5 -266.3 15.9 -21.6 1.6 -189.3 8.6
6 301.7 3.7 1.0 1.6 270.2 6.7
7 119.8 14.0 58.8 2.7 107.2 7.1
8 -413.7 5.6 -0.9 1.3 -329.8 11.6
9 -174.2 22.1 -175.2 15.4 -166.3 8.4
10 244.3 7.8 250.3 12.8 275.4 32.6
11 91.9 18.2 85.4 12.9 69.7 4.4
12 -306.0 5.3 -317.2 11.4 -318.7 27.6
Medial face on 
implant head 13 - - -151.5 3.4 -88.8 9.5
Lateral face on 
implant head 14 - - 103.0 15.4 38.3 2.3









TABLE XI.  Average mean and standard deviation between trials under 180 N. 
Mean St. Dev. Mean St. Dev. Mean St. Dev.
1 -148.8 5.2 -2.4 2.2 -60.8 4.8
2 124.3 10.6 4.5 2.6 74.0 10.4
3 102.9 6.6 2.8 1.9 41.6 5.6
4 -264.4 15.0 -4.4 1.5 -111.1 10.1
5 -149.3 6.1 -23.6 5.5 -87.3 7.4
6 171.5 8.1 70.3 8.1 152.3 7.5
7 75.2 6.8 18.1 4.5 54.1 5.2
8 -221.3 6.7 -92.5 6.6 -169.2 5.9
9 -92.7 7.5 -75.0 6.3 -71.5 10.9
10 129.8 6.4 141.5 6.3 145.2 16.8
11 39.9 7.4 17.2 3.2 22.6 8.4
12 -150.0 9.6 -174.0 4.6 -161.5 12.4
Medial face on 
implant head 13 - - -76.8 5.6 -57.4 9.0
Lateral face on 







Cemented (με)Intact (με) Press Fit (με)
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TABLE XII.  Average mean and standard deviation between trials under 360 N. 
Mean St. Dev. Mean St. Dev. Mean St. Dev.
1 -293.9 9.3 -3.0 2.7 -128.5 1.8
2 254.8 6.4 3.8 1.8 141.3 3.7
3 202.4 8.4 3.7 1.2 82.3 2.8
4 -531.3 9.8 -7.0 2.1 -241.0 3.8
5 -294.9 15.5 -47.8 4.7 -189.9 3.3
6 340.0 7.5 126.6 3.8 300.0 2.9
7 147.6 14.5 37.0 4.9 106.7 4.2
8 -439.5 8.8 -165.9 4.4 -346.2 3.7
9 -187.4 14.5 -154.2 7.9 -161.2 6.2
10 250.1 9.7 274.6 5.0 272.3 8.2
11 81.0 13.2 40.4 8.8 44.6 5.3
12 -296.6 8.9 -335.1 8.0 -325.0 8.7
Medial face on 
implant head 13 - - -164.6 5.8 -121.5 4.7
Lateral face on 







Cemented (με)Intact (με) Press Fit (με)
 
Similar results for the individual femurs are shown in the tables located in the 
appendix.  The maximum standard deviation is 40.5 με for the 180 N loading cases, as 
reported by Table IX, and 32.6 με for the 360 N loading cases, as reported by Table X, 
when comparing each individual test femur.  From Tables XI and XII it is evident that 
data is precise and that there is very little variation since the maximum standard deviation 
is only 15.0 με for the 180 N loading cases and 15.5 με for the 360 N loading cases.  
Also, from the above tables it is evident that each femur was statistically similar to the 




Modular implants are primarily used for patients who have little or no bone in the 
proximal region.  For this reason, modular implants are not designed to have a tight fit in 
the proximal region, specifically between the modular body and femur.  Since the 
proximal body made virtually no contact with the bone in the proximal area of the bone, 
essentially none of the load was distributed in the proximal region.  Therefore, the strains 
measured by the strain gages mounted in the proximal area were minimal and total stress 
shielding occurred. 
On average the test femurs exhibited stress shielding in the proximal and mid-stem 
regions since the surface strains in the proximal and mid-stem regions did not return to 
the intact levels after completing Phase II and Phase III.  Similar results were observed 
for each individual test femur as shown in the appendix. 
The strain levels were not expected to return to intact levels (Phase I) after 
completing Phase II and Phase III due to the high stiffness incorporated into the modular 
implant.  The implant itself is designed to transfer strains throughout the stem.  It is 
important to understand that there was a significant increase in strain in the proximal and 
mid-stem regions, thus the overall strain in the distal-stem region was reduced.  Over the 
course of time this will protect the stem from potential fracture or failure while promoting 
bone growth in the proximal and mid-stem regions.  This will undoubtedly extend the 
lifetime of the implant and lower the possibility of complications. 
The addition of hydroxyapatite bone cement had two successful outcomes.  First, the 
strain in the proximal region increased significantly, which should reduce the stress in the 
implant and slow bone resorption.  Second, there was a significant reduction of strain at 
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the interface where the body contacts the stem, which should reduce the chance of 
fracture at the interface. 
Two different loads of 180 N and 360 N were applied to each test femur while in the 
intact state, again in the press-fit state, and finally when hydroxyapatite bone cement was 
administered around the modular body in the proximal region.  On average, the 180 N 
loading case was approximately half of the 360 N loading case.  This is important in 
understanding that the surface strain levels are linear with respect to the loading range 
with a slope of approximately one half.  For extremely low load cases or extremely high 
load cases this relationship, though, may no longer remain linear. 
The load cell used in this study incorporated a range of 0 to 360 N.  Relatively small 
strain standard deviations were achieved in this study since the load cell allowed a 
constant load to be maintained, thereby resulting in a small strain variation.  In a study, 
conducted by Fries,35 that used the same test fixtures, but did not incorporate the same 
load cell, much larger standard deviations between the range of 53 με – 123 με were 
achieved as compared to standard deviations between the range of 6.4 με – 15.5 με that 
were achieved in this study.  The low and small range of standard deviations in this study 




Overall, all of the strain gages in the proximal region and mid-stem region 
experienced a dramatic drop in surface strain after the insertion of the modular implant.  
Additionally, the distal-stem level antero-medial and postero-lateral areas experienced a 
reduction in surface strains and stress shielding effects.   
The greatest amount of stress shielding occurred in the proximal region since there 
was very little or no contact between the modular body and surrounding bone.  The 
surface strain on the modular body was relatively low compared to the surface strains 
experienced by the test femur.  The highest modular body surface strains were seen on 
the medial face of each modular body, which was in compression when loaded. 
Overall, all femurs exhibited an increase in surface strains in all three examined 
regions after the addition of hydroxyapatite bone cement.  On average, the surface strains 
returned to 46 % of the intact levels in the proximal region, 74 % in the mid-stem region, 
and 84 % in the distal-stem region.  Stress shielding was still evident since the surface 
strains in the proximal regions did not return to the intact level.  The surface strains on 
the modular implants were reduced after the addition of hydroxyapatite.  On average the 
surface strains were reduced by 20 %.  The surface strains were low compared to strains 
that would be expected to represent stresses sufficient to cause implant failure. 
Overall, there is little variation in the results from the two leg stance model since the 
maximum standard deviation for the 180 N loading cases was 15.0 με while the 
maximum standard deviation for the 360 N loading cases was 15.5 με.   
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VIII. RECOMMENDATIONS 
The hydroxyapatite bone cement did increase the surface strains in the proximal and 
mid-stem regions, but they did not return to intact level.  Therefore, in revision total hip 
arthroplasty it is recommended to supplement the proximal femur with hydroxyapatite 
bone cement or graft in cases of significant bone loss. This will allow the prosthesis to 
load the proximal femur and reduce the strain on the implant stem and avoid significant 
stress shielding associated with this reconstructive hip design. 
It is also recommended that further testing be performed on each test femur that 
involves more rigorous action.  The femurs in this study were primarily tested under 
static loading due to the ease of data collection and test setup.  Fatigue or cyclic loading 
cases are suggested and single leg stance loading is recommended to understand if other 
factors will affect the performance of the hydroxyapatite on restoring surface strain on 
the femur. 
It is recommended that further testing be performed on the modular implants 
especially at the junction where the body meets the stem.  The surface strains were 
relatively low for the type of loading performed in this study.  Suggested loading 
conditions include impulse loading or cyclic loading to see if the chance of failure is 
increased. 
Finally, it is recommended that finite element analysis be performed on the femur and 
modular implant using the dual leg stance model.  Boundary conditions should be defined 
and the proper loading conditions should be applied to the solid model.  The FEA results 
can then be compared to the experimental data collected in this study. 
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FIGURE 37.  Measured intact, press fit, and cemented surface strains with a 180 N load 
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FIGURE 38.  Measured intact, press fit, and cemented surface strains with a 180 N load 
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FIGURE 39.  Measured intact, press fit, and cemented surface strains with a 180 N load 
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FIGURE 40.  Measured intact, press fit, and cemented surface strains with a 180 N load 
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FIGURE 41.  Measured intact, press fit, and cemented surface strains with a 180 N load 
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FIGURE 42.  Measured intact, press fit, and cemented surface strains with a 180 N load 
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FIGURE 43.  Measured intact, press fit, and cemented surface strains with a 180 N load 












1 2 3 4 5 6 7 8 9 10 11 12 13 14
Proximal Region Mid-Stem Region Distal-Stem Region Body









FIGURE 44.  Measured intact, press fit, and cemented surface strains with a 360 N load 
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FIGURE 45.  Measured intact, press fit, and cemented surface strains with a 360 N load 
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FIGURE 46.  Measured intact, press fit, and cemented surface strains with a 360 N load 
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FIGURE 47.  Measured intact, press fit, and cemented surface strains with a 360 N load 
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FIGURE 48.  Measured intact, press fit, and cemented surface strains with a 360 N load 
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FIGURE 49.  Measured intact, press fit, and cemented surface strains with a 360 N load 
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FIGURE 50.  Measured intact, press fit, and cemented surface strains with a 360 N load 




TABLE XIII.  Percent strain decrease between press fit and cemented loading cases on 
modular body. 
4139 4140 4141 4142 4470 4471 4472
Medial face on body 13 20.4% 47.7% 49.5% 51.6% 66.6% 16.4% 31.0%
Lateral face on body 14 31.3% 13.1% 27.5% 39.9% 42.3% 23.1% 45.3%
25.9% 30.4% 38.5% 45.8% 54.5% 19.8% 38.2%
Femur #Gage # and Location
Overall  
TABLE XIV.  Mean and standard deviation between trials under 180 N for femur #4140. 
Mean St. Dev. Mean St. Dev. Mean St. Dev.
1 -169.5 5.8 -0.3 4.4 -82.5 1.8
2 122.4 10.9 0.3 3.6 77.3 4.1
3 92.6 11.5 3.5 2.9 40.0 1.9
4 -259.2 13.5 -4.7 1.0 -134.5 6.9
5 -168.6 11.0 -57.6 15.3 -134.7 4.2
6 137.8 6.6 86.8 15.1 133.7 3.3
7 72.3 9.3 6.8 6.2 54.7 2.4
8 -225.8 11.9 -173.2 13.6 -203.4 1.6
9 -117.5 5.2 -107.9 7.2 -110.1 3.5
10 107.6 6.2 122.9 5.7 105.6 6.1
11 37.4 8.5 21.6 5.1 23.8 5.4
12 -158.8 4.3 -172.1 4.8 -170.9 15.7
Medial face on 
implant head 13 - - -80.3 6.9 -44.3 2.6
Lateral face on 
implant head 14 - - 53.5 5.5 52.4 1.7

















TABLE XV.  Mean and standard deviation between trials under 360 N for femur #4140. 
Mean St. Dev. Mean St. Dev. Mean St. Dev.
1 -332.9 5.8 -0.6 4.4 -177.4 1.2
2 242.7 2.2 -0.7 4.6 147.5 2.4
3 178.7 7.8 2.1 1.1 80.4 3.2
4 -509.8 5.1 -13.3 2.6 -280.9 3.4
5 -334.4 8.4 -143.1 13.7 -288.5 2.0
6 268.3 2.0 154.3 15.1 272.1 3.6
7 134.1 5.5 24.7 13.9 114.1 3.4
8 -452.2 5.3 -339.1 21.1 -425.3 1.8
9 -227.9 3.7 -228.3 4.0 -228.3 6.1
10 210.1 5.9 223.1 0.5 224.8 2.7
11 73.2 4.4 53.0 10.7 48.7 3.6
12 -308.9 3.8 -327.6 7.2 -330.8 5.0
Medial face on 
implant head 13 - - -169.6 7.0 -94.1 1.6
Lateral face on 
implant head 14 - - 99.8 11.3 92.0 5.7








TABLE XVI.  Mean and standard deviation between trials under 180 N for femur #4141. 
Mean St. Dev. Mean St. Dev. Mean St. Dev.
1 -111.8 5.8 -2.5 1.7 -36.4 2.6
2 133.8 5.4 1.6 1.8 79.6 10.3
3 97.4 7.4 2.0 1.8 33.7 4.0
4 -251.2 1.4 -1.7 1.3 -94.6 10.6
5 -120.9 10.9 -11.5 4.9 -68.3 11.1
6 174.3 6.9 81.3 15.4 161.2 11.4
7 55.1 11.0 9.5 9.6 51.4 7.5
8 -197.6 6.1 -113.8 3.4 -143.8 7.0
9 -58.8 18.5 -68.5 12.4 -45.4 16.1
10 144.0 8.2 123.7 21.9 146.7 15.6
11 22.4 16.2 12.4 0.8 27.3 10.0
12 -162.9 12.3 -174.2 10.8 -148.8 9.6
Medial face on 
implant head 13 - - -93.0 2.3 -47.6 3.2
Lateral face on 
implant head 14 - - 68.2 0.7 60.6 4.9










TABLE XVII.  Mean and standard deviation between trials under 360 N for femur 
#4141. 
Mean St. Dev. Mean St. Dev. Mean St. Dev.
1 -236.7 4.7 -6.6 3.4 -79.4 1.6
2 259.5 6.4 2.5 1.2 145.9 7.0
3 199.8 11.7 1.4 0.5 69.6 5.6
4 -499.2 0.5 -4.4 5.3 -196.5 3.2
5 -255.7 14.0 -10.8 7.0 -161.3 4.5
6 331.8 5.0 148.5 2.7 303.6 2.2
7 119.4 19.5 17.9 7.5 94.6 5.3
8 -383.0 7.8 -168.1 1.1 -299.2 2.1
9 -141.5 28.5 -128.4 6.2 -121.5 7.0
10 269.1 16.5 255.9 2.4 262.9 4.5
11 62.4 25.7 35.7 6.9 51.6 13.8
12 -309.2 21.0 -319.2 7.7 -300.9 8.4
Medial face on 
implant head 13 - - -186.8 5.0 -94.8 0.9
Lateral face on 
implant head 14 - - 126.7 0.9 99.1 3.1



















TABLE XVIII.  Mean and standard deviation between trials under 180 N for femur 
#4142. 
Mean St. Dev. Mean St. Dev. Mean St. Dev.
1 -147.7 6.6 -3.4 1.4 -71.0 1.4
2 61.9 3.8 3.1 1.1 44.4 11.9
3 79.1 4.3 4.3 3.1 33.7 8.4
4 -242.7 4.1 -2.8 4.6 -95.4 6.1
5 -154.9 3.0 -26.3 8.1 -83.8 1.7
6 145.3 2.3 97.6 4.6 135.4 5.5
7 31.1 2.8 18.8 4.8 26.3 4.4
8 -198.3 4.6 -89.4 9.4 -149.7 0.5
9 -83.1 6.1 -86.8 3.8 -65.7 20.5
10 131.2 4.0 131.2 2.4 151.8 26.2
11 42.4 4.6 35.0 2.5 29.0 6.7
12 -125.9 5.3 -137.8 3.6 -127.7 30.4
Medial face on 
implant head 13 - - -98.1 11.8 -73.3 8.7
Lateral face on 
implant head 14 - - 72.8 5.8 57.4 2.0








TABLE XIX. Mean and standard deviation between trials under 360 N for femur #4142. 
Mean St. Dev. Mean St. Dev. Mean St. Dev.
1 -278.2 2.1 -0.7 0.5 -132.4 0.7
2 127.8 4.1 3.3 0.1 85.0 1.6
3 145.8 3.0 11.4 1.7 68.9 2.6
4 -475.3 3.0 -2.4 3.0 -230.4 1.9
5 -296.7 16.2 -49.0 3.5 -184.9 1.8
6 287.8 5.8 188.4 0.4 264.6 3.0
7 60.6 17.2 45.6 4.7 49.0 5.6
8 -385.0 6.9 -173.8 2.5 -307.7 3.7
9 -157.4 6.9 -168.5 5.5 -159.5 8.5
10 245.9 13.0 262.8 3.1 274.6 5.6
11 73.3 8.7 68.4 7.4 57.0 7.6
12 -249.3 13.5 -273.3 6.4 -281.6 12.1
Medial face on 
implant head 13 - - -190.3 8.4 -142.2 1.0
Lateral face on 
implant head 14 - - 136.2 8.3 97.7 2.4









TABLE XX.  Mean and standard deviation between trials under 180 N for femur #4470. 
Mean St. Dev. Mean St. Dev. Mean St. Dev.
1 -204.6 6.3 -1.5 4.4 -60.3 9.4
2 157.4 11.2 3.5 2.9 107.5 22.5
3 140.1 3.9 -0.1 4.0 51.5 13.9
4 -306.5 33.1 -6.3 0.7 -107.3 3.2
5 -175.5 3.4 -6.6 4.9 -77.5 8.6
6 204.0 13.9 46.5 9.4 185.1 14.1
7 110.8 2.9 2.8 4.5 72.4 12.8
8 -255.0 10.0 -59.1 4.6 -181.6 8.3
9 -108.5 5.0 -73.4 6.8 -62.0 14.9
10 155.8 7.4 159.2 3.8 172.5 19.2
11 45.8 3.0 11.1 5.0 23.2 18.5
12 -184.8 4.8 -195.2 4.1 -182.3 14.2
Medial face on 
implant head 13 - - -66.8 11.2 -39.3 22.3
Lateral face on 
implant head 14 - - 49.1 5.8 45.3 19.5








TABLE XXI.  Mean and standard deviation between trials under 360 N for femur #4470. 
Mean St. Dev. Mean St. Dev. Mean St. Dev.
1 -416.5 14.6 -1.6 4.7 -136.1 2.1
2 315.8 10.3 0.0 0.8 186.4 4.0
3 280.9 10.0 -0.3 1.7 92.3 1.5
4 -643.5 3.4 -7.8 1.1 -231.6 2.7
5 -350.3 16.9 -29.6 1.4 -175.5 1.2
6 398.3 14.0 100.2 1.7 350.5 0.8
7 221.9 13.9 24.2 1.5 134.0 2.6
8 -504.9 12.6 -126.0 3.7 -369.4 2.4
9 -215.7 17.3 -150.0 1.5 -158.8 4.6
10 296.8 11.4 309.6 1.9 302.9 4.9
11 94.1 16.4 26.5 0.8 31.1 3.7
12 -359.2 12.5 -382.7 1.8 -378.0 4.1
Medial face on 
implant head 13 - - -145.3 10.0 -104.1 2.3
Lateral face on 
implant head 14 - - 97.8 8.0 41.7 1.5









TABLE XXII.  Mean and standard deviation between trials under 180 N for femur 
#4471. 
Mean St. Dev. Mean St. Dev. Mean St. Dev.
1 -135.6 3.1 -0.9 0.8 -63.9 10.5
2 147.0 7.0 14.9 1.8 82.6 5.4
3 123.6 6.9 6.1 0.5 71.4 6.1
4 -278.9 9.7 -12.3 1.9 -138.2 9.3
5 -147.5 5.4 -43.8 0.5 -103.7 5.0
6 207.3 9.4 81.4 5.6 147.7 5.4
7 129.7 9.3 42.9 3.2 109.6 1.5
8 -225.1 9.6 -78.6 7.3 -143.9 2.3
9 -95.2 9.4 -55.1 5.3 -75.6 1.1
10 115.1 3.8 152.9 1.3 122.8 3.8
11 45.3 7.3 -3.5 3.4 17.9 4.9
12 -112.5 3.7 -171.5 4.8 -138.8 6.6
Medial face on 
implant head 13 - - -56.1 2.7 -58.7 1.9
Lateral face on 
implant head 14 - - 50.2 2.3 42.0 4.3



















TABLE XXIII.  Mean and standard deviation between trials under 360 N for femur 
#4471. 
Mean St. Dev. Mean St. Dev. Mean St. Dev.
1 -259.2 16.8 -1.3 0.2 -129.7 3.1
2 296.7 10.6 12.8 2.2 150.9 0.7
3 236.4 13.6 5.5 1.0 141.9 2.0
4 -554.2 15.2 -15.2 0.6 -284.3 3.9
5 -279.3 22.2 -76.6 3.6 -213.5 2.7
6 420.1 12.9 120.1 3.0 295.7 1.4
7 243.7 24.1 62.3 1.4 220.3 4.5
8 -452.6 12.4 -117.5 0.5 -288.7 2.1
9 -197.3 12.8 -109.7 19.4 -164.7 7.4
10 220.5 7.2 295.2 13.9 244.6 3.0
11 93.5 14.1 -1.0 18.7 43.9 2.6
12 -219.2 3.4 -332.1 18.1 -273.2 2.2
Medial face on 
implant head 13 - - -127.6 3.5 -118.8 1.2
Lateral face on 
implant head 14 - - 102.9 4.5 67.5 2.5



















TABLE XXIV.  Mean and standard deviation between trials under 180 N for femur 
#4472. 
Mean St. Dev. Mean St. Dev. Mean St. Dev.
1 -165.0 7.7 -3.3 0.8 -39.3 4.6
2 148.9 10.6 6.8 6.2 75.1 10.0
3 105.2 8.5 1.5 0.7 36.7 1.8
4 -278.3 2.7 -0.9 0.6 -110.2 15.7
5 -140.2 3.4 -4.1 3.1 -52.8 1.6
6 178.6 9.1 84.8 2.7 171.9 5.2
7 63.8 5.9 12.5 0.6 17.7 3.9
8 -237.9 1.0 -117.2 4.9 -198.0 1.8
9 -93.9 0.7 -57.8 4.7 -60.6 9.4
10 131.1 6.7 166.0 2.9 162.1 8.0
11 37.3 4.0 10.1 1.3 7.9 2.8
12 -149.1 30.4 -200.3 0.4 -188.3 6.1
Medial face on 
implant head 13 - - -86.3 2.8 -94.6 10.8
Lateral face on 
implant head 14 - - 61.0 3.5 44.8 14.3



















TABLE XXV.  Mean and standard deviation between trials under 360 N for femur 
#4472. 
Mean St. Dev. Mean St. Dev. Mean St. Dev.
1 -324.6 13.9 -4.7 2.8 -88.9 2.9
2 321.6 8.3 6.7 2.3 154.4 3.7
3 215.4 8.8 3.3 0.8 63.8 1.8
4 -571.8 14.8 -3.0 1.1 -246.6 4.9
5 -281.5 15.4 -3.8 2.0 -116.7 2.4
6 372.0 9.0 173.6 2.0 343.4 2.3
7 133.9 7.3 25.8 2.7 27.5 0.9
8 -485.3 11.4 -235.8 0.6 -403.3 1.9
9 -197.8 10.1 -119.2 3.7 -129.0 1.6
10 264.2 6.0 325.6 0.2 320.8 3.8
11 78.5 4.8 14.7 4.3 10.4 1.5
12 -324.2 3.1 -393.4 3.7 -392.1 1.5
Medial face on 
implant head 13 - - -180.8 3.0 -207.4 16.2
Lateral face on 
implant head 14 - - 126.8 3.5 91.1 11.4
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